- Home
- CRGY vs RCKT Comparison
CRGY vs RCKT Comparison
Compare CRGY & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGY
- RCKT
- Stock Information
- Founded
- CRGY 1986
- RCKT 1999
- Country
- CRGY United States
- RCKT United States
- Employees
- CRGY 987
- RCKT N/A
- Industry
- CRGY Oil & Gas Production
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- CRGY Energy
- RCKT Health Care
- Exchange
- CRGY Nasdaq
- RCKT Nasdaq
- Market Cap
- CRGY 2.2B
- RCKT 328.6M
- IPO Year
- CRGY N/A
- RCKT N/A
- Fundamental
- Price
- CRGY $8.57
- RCKT $3.21
- Analyst Decision
- CRGY Buy
- RCKT Buy
- Analyst Count
- CRGY 11
- RCKT 13
- Target Price
- CRGY $15.89
- RCKT $12.96
- AVG Volume (30 Days)
- CRGY 5.6M
- RCKT 5.7M
- Earning Date
- CRGY 11-03-2025
- RCKT 11-06-2025
- Dividend Yield
- CRGY 5.54%
- RCKT N/A
- EPS Growth
- CRGY N/A
- RCKT N/A
- EPS
- CRGY 0.12
- RCKT N/A
- Revenue
- CRGY $3,468,319,000.00
- RCKT N/A
- Revenue This Year
- CRGY $26.44
- RCKT N/A
- Revenue Next Year
- CRGY N/A
- RCKT $108.43
- P/E Ratio
- CRGY $74.35
- RCKT N/A
- Revenue Growth
- CRGY 32.84
- RCKT N/A
- 52 Week Low
- CRGY $6.83
- RCKT $2.19
- 52 Week High
- CRGY $16.94
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- CRGY 42.71
- RCKT 48.07
- Support Level
- CRGY $8.22
- RCKT $3.12
- Resistance Level
- CRGY $8.93
- RCKT $3.30
- Average True Range (ATR)
- CRGY 0.43
- RCKT 0.18
- MACD
- CRGY -0.09
- RCKT -0.02
- Stochastic Oscillator
- CRGY 20.06
- RCKT 15.41
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.